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Abstract
Objectives: To explore the function of p38MAPK and caspase-3 in DADS-induced apoptosis in human HepG2 cells, 
and discuss the signal transduetion mechanism of HepG2 cells in the apoptosis process induced by DADS by using the 
inhibitors of p38MAPK (SB203580) and caspase-3 (Z-DEVD-FMK).
Methods: After the human HepG2 cells had been treated with the DADS and inhibitors for 24 h, cell viability was 
determined by the MTT method, apoptosis was evaluated by flow cytometry (FCM) and the expressions of p38MAPK 
and caspase-3 were measured by western-blot.
Results: Our results indicated that DADS activities the p38MAPK and caspase-3, but the inhibitors, SB203580 and Z-
DEVD-FMK (for p38MAPKand for caspase-3, respectively), both have the effect of inhibitory activity on P38MAPK and 
caspase-3. Furthermore, a combination treatment with both DADS and inhibitor (SB203580 or Z-DEVD-FMK) decreases 
the inhibitory and apoptotic activity of HepG2 cells increased compared with DADS-treated.
Conclusions: Our data indicate that p38MAPK and caspase-3 are involved in the process of DADS-induced apoptosis 
in human HepG2 cells and interact with each other.
Background
The MAPK (mitogen-activated protein kinase) system is
a cluster of serine/threonine protein kinases in the cells,
and the activitied MAPKs participate in a variety of cellu-
lar responses including genetic transcription, inducing
cell apoptosis, maintaining cell and regulating cell cycle,
and so on [1-3]. The p38MAPK is the key member of the
MAPK family and more commonly activated in response
to cytokines, stress and cellular damage [4,5]. A large
number of studies have shown that the activity of
p38MAPK is necessary in the apoptosis process induced
by various anti-cancer drugs. Caspase enzymes play a
very important role when cells started apoptosis as the
central effector of apoptosis. Caspase-3, is the ultimate
enforcer of apoptotic death, which can cleavage many
proteins of important structure and function directly[6].
Diallyl disulfide (DADS) is one kind of oil-soluble sulfur
organic compounds, it is a potential broad-spectrum
anti-cancer drug. Studies have shown that DADS can
inhibit human tumor cells grow including those of colon,
lung, skin, breast, liver origins and prostate [7-10]. There
are also lots of reports about the caspase-3 involvement
during apoptosis process with DADS induction, such as
The DADS induced apoptosis by the activation of cas-
pase-3 in human leukemia HL-60 cells in a dosedepen-
dent manner, DADS promoted caspase-3 activity and
increased cyclin E and decreased CDK2 gene expression
which may lead to the G2/M arrest of T24 cells, Effects of
diallyl disulfide (DADS) on expression of apoptosis asso-
ciated proteins in androgen independent human prostate
cancer cells (PC-3) [11,12], and so on. Our previous stud-
ies have shown that the activated p38MAPK appears to
play a cytoprotective role, and the MAPK specific inhibi-
tors enhance apoptotic effects in HepG2 hepatoma cells
w i t h  D A D S  t r e a t m e n t [ 1 3 ] .  I n  t h i s  r e p o r t  w e  u s e d  t h e
inhibitors of p38MAPK (SB203580) and caspase-3 (Z-
DEVD-FMK) to detect the relation of p38MAPK and cas-
pase-3 in the apoptosis process induced by DADS, we
found that p38MAPK and caspase-3 are involved in the
process of DADS-induced apoptosis in human HepG2
cells and interact with eachother.
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Materials and methods
Major reagents
DADS (80% purity) was purchased from Fluka Co., Dul-
becco's modified Eagle medium (DMEM) medium, BSA
and SB203580 were purchased from Sigma. Z-DEVD-
FMK was purchased from CALBIOCHEM (USA), goat
horseradish peroxidase (HRP)-conjugated anti-rabbit
secondary antibody were purchased from Santa Cruz
Biotech. Antibodies to p38, phospho-p38 (p-p38), cas-
pase-3 were purchased from Cell Signaling.
Cell culture
HepG2 (the human hepatoma cell line) were provided by
the Xiangya school of medicine and cultured in DMEM
with 10% heat-inactivated fetal bovine serum (FBS), ben-
zylpenicillin (100 kU/L) and streptomycin (100 mg/L) at
37°C in an incubator containing humidified air with 5%
CO2.
Cell viability assay
Cells were seeded into 96-well plates at 1 × 104 cells per
well 24 h before treatment. The cultures were then rinsed
in phenol-free DMEM medium and incubated with
respective test substances in phenol-free and serumfree
DMEM for 24 h. In the inhibition test, Cells were treated
with DADS after being treated with inhibitors 30 min. At
the end of this time interval, 20 μl (5 mg/ml) MTT [3-
(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide] was added to each well, and after incubation at
37°C for 4 h the MTT solution was removed and 200 μl of
dimethylsulfoxide (DMSO) was added to dissolve the
crystals. The absorbance of each well at 570 nm was mea-
sured.
Flow cytometry analysis
Cells were seeded into 100 ml cell culture bottles at 12 ×
106 cells 24 h before treatment. Then cells were treated
according to the aforementioned method and incubated
for 24 h. Afterwards, cells were collected, made into sin-
gle cell suspension and centrifuged at 800 g for 5 min.
Discard the supernatant, washed cells three times with
the cool PBS and fixed them 24 h with cool alcohol at 4°C.
Taked 1 ml cell suspension (106/ml), washed it three
times with the cool PBS, treated it with RNase for 30 min
at 37°C, and stained it with PI for 30 min at 37°C in a dark
environment. Then the flow cytometry analysis can be
carried out.
Western-blotting
Taked the cells in the logarithmic growth phase, treated
them according to the aforementioned method and incu-
bated for 24 h. After fragmentation on ice for 20 min, the
lysates were centrifuged at 15,000 g for 10 min at 4°C, col-
lected the protein and quantitated it with the BCA
method, electrophoresed and isolated protein by the
SDS-PAGE (10%), used the electrotransfer method, car-
ried out the blocking and hybridization on the cellulose
nitrate film, detected the protein expression of cells using
the ECL western blotting method. The densities of pro-
tein bands were calculated using the Quantyone software.
Statistics
Data are expressed as mean ± S.D of three independent
experiments and evaluated by one-way analysis of vari-
ance (ANOVA). Significant differences were established
at P < 0.05.
Results
Changes of cell activity
Cell viability was determined by the MTT assay. As
shown in Figure 1. After treatment and incubated for 24
h, the inhibition ratio of treated with 10 μmol/L
SB203580 and 100 μmol/L DADS was 19.45% at 24 h, and
the inhibition ratio of treated with 10 μmol/L Z-DEVD-
FMK and 100 μmol/L DADS was 17.64% at 24 h, both of
them were lower than the inhibition ratio of treated with
100 μmol/L DADS at 24 h, but they were both higher
than the inhibition ratio of treated with 10 μmol/L
SB203580 and 10 μmol/L Z-DEVD-FMK respectively
(9.73% and 6.77%).
Flow-cytometric analysis of apoptosis
The results of flow cytometry analysis showed, the rate of
SB203580-DADS group and SB203580-Z-DEVD-FMK
group was 18.98% and 17.45% respectively, 1.86% of con-
trol group, 8.50% when treated with SB203580 (10 μmol/
L), 6.02% when treated with Z-DEVD-FMK (10 μmol/L),
and 25.23% when treated with DADS (Figure 2). These
results suggested that inhibitors of P38MAPK and cas-
Figure 1 Results of the MTT assay. Lane 1: control (untreated), lane 
2: Z-DEVD-FMK (10 μmol/L), lane 3: SB203580 (10 μmol/L), lane 4: treat-
ed with DADS (100 μmol/L) after being treated with SB203580 (10 
μmol/L) for 30 min lane 5: treated with DADS (100 μmol/L) after being 
treated with Z-DEVD-FMK (10 μmol/L) for 30 min, lane6: DADS (100 
μmol/L). Cells viability was determined by MTT assay as described in 
Materials and Methods. Data are expressed as mean ± S.D and evaluat-
ed by one-way analysis of variance (ANOVA). Results are representative 
of three replicates (P < 0.01).Ji et al. Journal of Experimental & Clinical Cancer Research 2010, 29:50
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pase-3 both had obvious effect of inhibiting apoptosis
(Figure 3).
Western-blot analysis
After various treatment for 24 h, the zymogen bands of
caspase-3 treated with DADS (100 μmol/L) became thin-
ner significantly compared with the control gtoup, prov-
ing that DADS could advance the activity of caspase-3;
after treated with SB203580 (10 μmol/L) and Z-DEVD-
FMK (10 μmol/L) respectively, the zymogen bands of cas-
pase-3 became thicker significantly compared with
treated with DADS (100 μmol/L), but compared with the
DADS (100 μmol/L) group that 30 minutes ahead of
schedule by adding inhibitor, the band is only slightly
thinner (Figure 4).
Similarly, SB203580 (10 μmol/L) and Z-DEVD-FMK
(10 μmol/L) had inhibition effect on the P-p38 MAPK,
When SB203580(or Z-DEVD-FMK) was added to HepG2
hepatoma cells for 30 min before DADS treatment or
only added SB203580 (or Z-DEVD-FMK) to HepG2
hepatoma cells, P-p38 MAPK was markedly decreased,
but DADS induced activations of P-p38 MAPK, com-
pared to DADS-treatment alone or no treatment (Figure
4).
These results confirm that SB203580 and Z-DEVD-
FMK could inhibit the activity of P-p38 MAPK and cas-
pase-3. But the inhibition of SB203580 was stronger than
Z-DEVD-FMK, comparatively (Figure 5).
Figure 2 Effects of each group on apoptosis in in human HepG2 cells. A. Control (untreated), B. Z-DEVD-FMK (10 μmol/L), C. SB203580 (10 μmol/
L), D. treated with DADS (100 μmol/L) after being treated with SB203580 (10 μmol/L) for 30 min, E. treated with DADS (100 μmol/L) after being treated 
with Z-DEVD-FMK (10 μmol/L) for 30 min, F. DADS (100 umol/L). Results are representative of three replicates (P < 0.01).Ji et al. Journal of Experimental & Clinical Cancer Research 2010, 29:50
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Discussion
Apoptosis is a very complex process with the complexity
and diversity, different cells in different stress have differ-
ent signal transduction pathways. Extracellular signals
how pass to cells and cause cells to the corresponding
reaction is very important to the occurrence of apoptosis
in the process of cell apoptosis.
The MAPK (mitogen-activated protein kinase) system
is a cluster of intracellular serine/threonine protein
kinases, playing an important role in a variety of signal
transduction pathways of the mammalian cells. In recent
years, many research report that apoptosis signal trans-
duction and activation of caspase have a closely relation-
ship, and have found 16 members of caspase family in
mammalian cells [14-16]. All the Caspase exit in the form
of inactive zymogen, can lead to caspase cascade reaction
after be activitied, and eventually induce apoptosis.
Undynamic caspase-3 will trigger apoptosis when it is
activitied, and play a very important role when cells
started apoptosis as the central effector of apoptosis [17-
20].
Our previous work has demonstrated that DADS tran-
siently activates both p38MAPK and p42/44MAPK while
it induces apoptosis in a time and dose dependent man-
ner in human HepG2 hepatoma cells[13]. The present
study focuses on the role of p38MAPK and caspase-3 in
cell apoptosis and DADS-induced apoptosis. To test the
relation of p38MAPK and caspase-3 in the apoptosis pro-
cess of human HepG2 cells induced by DADS, we used
the inhibitors of p38MAPK (SB203580) and caspase-3 (Z-
DEVD-FMK), the methods of MTT, flow cytometry anal-
ysis and western blot, The results presented in this study
established a potential role for inhibitors of p38MAPK
and caspase-3 in DADS-induced apoptosis. First, inhibi-
tor (SB203580 or Z-DEVD-FMK) have the effect of inhib-
itory activity on p38MAPK and caspase-3. Second, a
combination treatment with both DADS and inhibitor
(SB203580 or Z-DEVD-FMK) decreases the inhibitory
and apoptotic activity of HepG2 cells increased compared
with DADS-treated (Figure 1, Figure 3, Figure 4 and Fig-
ure 5). The combined effect suggests a co-chemocyto-
toxic value in human HepG2 cells. In conclusion, our
results show that p38MAPK and caspase-3 are involved
in the process of DADS-induced apoptosis in human
HepG2 cells and interact with each other.
At present, there have made some progress on the
effect of MAPK signaling pathway in cellular apoptosis,
but need in-depth study to fully reveal its mechanisms of
action. Our results show that p38MAPK and caspase-3
are involved in the process of DADS-induced apoptosis in
human HepG2 cells, enhance DADS-induced apoptosis
and interact with each other, but its mechanism remains
to be further discussed [21-24]. Further study the rela-
Figure 3 Results of the flow cytometry analysis. Data are expressed 
as mean ± S.D and evaluated by one-way analysis of variance (ANOVA). 
The results are representative of three independent experiment.
Figure 4 Effects of each group on the protein expressions by 
Western blot. Lane 1: control (untreated), lane 2: treated with DADS 
(100 μmol/L) after being treated with SB203580 (10 μmol/L) for 30 min, 
lane 3: SB203580 (10 μmol/L), lane 4: Z-DEVD-FMK (10 μmol/L), lane 5: 
treated with DADS (100 μmol/L) after being treated with Z-DEVD-FMK 
(10 μmol/L) for 30 min, lane6: DADS (100 μmol/L). The results are rep-
resentative of three independent experiment.
Figure 5 Results of protein expression. Data are expressed as mean 
± S.D and evaluated by one-way analysis of variance (ANOVA). Results 
are representative of three replicates (P < 0.01).Ji et al. Journal of Experimental & Clinical Cancer Research 2010, 29:50
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tionship of MAPK signal transduction pathway and cas-
pase in the cellular apoptosis process, will have important
significance for studying anti-tumor mechanisms of
DADS and designing new drugs.
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